Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Cancer Institute & Hospital

Clinical trials sponsored by Jiangsu Cancer Institute & Hospital, explained in plain language.

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 1 Completed 1

Immunotherapy before standard care may boost survival in esophageal cancer

Disease control Ongoing

This phase 3 trial tests whether adding immunotherapy (sintilimab) and chemotherapy before standard chemoradiotherapy helps people with inoperable esophageal cancer live longer. About 242 adults aged 18-75 with stage 2-4A disease are participating. The study compares the new comb…

Phase: PHASE3 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control

Last updated May 14, 2026 12:03 UTC